Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes.

Angli Xue | Yang Wu | Zhihong Zhu | Futao Zhang | Kathryn E Kemper | Zhili Zheng | Loic Yengo | Luke R Lloyd-Jones | Julia Sidorenko | Yeda Wu | eQTLGen Consortium | Allan F McRae | Peter M Visscher | Jian Zeng | Jian Yang
Nature communications | 2018

Type 2 diabetes (T2D) is a very common disease in humans. Here we conduct a meta-analysis of genome-wide association studies (GWAS) with ~16 million genetic variants in 62,892 T2D cases and 596,424 controls of European ancestry. We identify 139 common and 4 rare variants associated with T2D, 42 of which (39 common and 3 rare variants) are independent of the known variants. Integration of the gene expression data from blood (n = 14,115 and 2765) with the GWAS results identifies 33 putative functional genes for T2D, 3 of which were targeted by approved drugs. A further integration of DNA methylation (n = 1980) and epigenomic annotation data highlight 3 genes (CAMK1D, TP53INP1, and ATP5G1) with plausible regulatory mechanisms, whereby a genetic variant exerts an effect on T2D through epigenetic regulation of gene expression. Our study uncovers additional loci, proposes putative genetic regulatory mechanisms for T2D, and provides evidence of purifying selection for T2D-associated variants.

Pubmed ID: 30054458

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NIGMS NIH HHS, United States
    Id: P01 GM099568
  • Agency: NIEHS NIH HHS, United States
    Id: R21 ES025052
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM075091
  • Agency: Wellcome Trust, United Kingdom
    Id: 208806/Z/17/Z
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH100141
  • Agency: NIA NIH HHS, United States
    Id: R01 AG042568

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


GWAS: Catalog of Published Genome-Wide Association Studies (tool)

RRID:SCR_012745

Catalog of published genome-wide association studies. Genome-wide set of genetic variants in different individuals to see if any variant is associated with trait and disease. Database of genome-wide association study (GWAS) publications including only those attempting to assay single nucleotide polymorphisms (SNPs). Publications are organized from most to least recent date of publication. Studies are identified through weekly PubMed literature searches, daily NIH-distributed compilations of news and media reports, and occasional comparisons with an existing database of GWAS literature (HuGE Navigator). Works with HANCESTRO ancestry representation.

View all literature mentions

DIAGRAM (tool)

RRID:SCR_015675

Consortium of researchers aiming to characterize the genetic basis of type 2 diabetes with a principal focus on samples of European descent. DIAGRAM also features a database of DIAGRAM publications and diabetes-related research data.

View all literature mentions

DrugBank (tool)

RRID:SCR_002700

Bioinformatics and cheminformatics database that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information.

View all literature mentions